Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region

被引：0
作者：
M. Chandran
P. J. Mitchell
T. Amphansap
S. K. Bhadada
M. Chadha
D.-C. Chan
Y.-S. Chung
P. Ebeling
N. Gilchrist
A. Habib Khan
P. Halbout
F. L. Hew
H.-P. T. Lan
T. C. Lau
J. K. Lee
S. Lekamwasam
G. Lyubomirsky
L. B. Mercado-Asis
A. Mithal
T. V. Nguyen
D. Pandey
I. R. Reid
A. Suzuki
T. T. Chit
K. L. Tiu
T. Valleenukul
C. K. Yung
Y. L. Zhao
机构：
[1] Singapore General Hospital,Department of Endocrinology, Osteoporosis and Bone Metabolism Unit
[2] Synthesis Medical NZ Limited,Department of Orthopedics
[3] Police General Hospital,Department of Endocrinology
[4] Postgraduate Institute of Medical Education and Research,Department of Endocrinology
[5] Hinduja Hospital and Research Centre,Internal Medicine
[6] National University Hospital Chu-Tung Branch,Department of Endocrinology and Metabolism
[7] Ajou University School of Medicine,Department of Medicine in the School of Clinical Sciences
[8] Monash Health,Section of Chemical Pathology, Department of Pathology and Laboratory Medicine
[9] Canterbury District Health Board,Department of Medicine
[10] Aga Khan University,Musculoskeletal and Metabolic Unit, Biomedical Research Center
[11] International Osteoporosis Foundation,Division of Rheumatology, Department of Medicine
[12] Subang Jaya Medical Centre,Department of Orthopedics
[13] Pham Ngoc Thach University of Medicine,Faculty of Medicine
[14] Bone and Muscle Research Group,Faculty of Medicine and Surgery
[15] Ton Duc Thang University,Endocrinology, Diabetes Division
[16] National University Hospital,Genetics and Epidemiology of Osteoporosis Laboratory, Bone Biology Division
[17] Beacon International Specialist Centre,Department of Orthopaedics
[18] University of Ruhuna,Faculty of Medical and Health Sciences
[19] Osteoporosis Australia,Department of Endocrinology, School of Medicine
[20] University of Santo Tomas,Polytrauma and Fragility Fracture team, Department of Orthopaedics and Traumatology
[21] Mithal,Department of Orthopedics
[22] M. Max Healthcare - Pan-Max,Department of Endocrinology and Patient Safety Unit
[23] Garvan Institute of Medical Reseach,Department of Obstetrics and Gynecology
[24] National Trauma Centre,undefined
[25] University of Auckland,undefined
[26] Fujita Health University,undefined
[27] East Yangon General Hospital,undefined
[28] Queen Elizabeth Hospital,undefined
[29] Bhumibol Adulyadej Hospital,undefined
[30] Raja Isteri Pengiran Anak Saleha Hospital,undefined
[31] Beijing United Family Hospital,undefined
来源：
Osteoporosis International | 2021年 / 32卷
关键词：
Asia-Pacific; Consensus; Guidelines; Osteoporosis; Standards of care;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1249 / 1275
页数：26
相关论文
共 526 条
[51]  
Kung A(2010)Time since prior fracture is a risk modifier for 10-year osteoporotic fractures J Bone Miner Res 25 1765-46
[52]  
Fujiwara S(2017)Imminent fracture risk Osteoporos Int 28 775-240
[53]  
Chan SP(2017)Imminent risk of fracture after fracture Osteoporos Int 28 26-1427
[54]  
Huang QR(2016)Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data Arch Osteoporos 11 287-751
[55]  
Rajatanavin R(2017)Determinants of short term fracture risk in patients with a recent history of low-trauma non-vertebral fracture Bone 105 1747-3793
[56]  
Tsai KS(2018)Characteristics of recurrent fractures Osteoporos Int 29 1-860
[57]  
Park HM(2020)Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures Osteoporos Int 31 1817-1155
[58]  
Reginster JY(2020)Adjusting conventional FRAX estimates of fracture probability according to the recency of sentinel fractures Osteoporos Int 31 1-1543
[59]  
Nguyen ND(2020)American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis – 2020 update Endocr Pract 26 230-224
[60]  
Frost SA(2018)Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial Lancet 391 1417-1408
12345678910